Metoprolol Succinate Tablet, Extended Release
Product Images NDC 68788-8312

3 FDA label images from Preferred Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68788-8312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (00df8655 C4ff 481f Bd4f E43b69b3a059 01)

Image (00df8655 C4ff 481f Bd4f E43b69b3a059 01)
Chemical structure diagram showing the molecular formula of metoprolol succinate, an active ingredient in METOPROLOL SUCCINATE extended release tablets. The structure includes the metoprolol moiety and the succinate component.*
FDA Label Image

Merit Hf (00df8655 C4ff 481f Bd4f E43b69b3a059 02)

Merit Hf (00df8655 C4ff 481f Bd4f E43b69b3a059 02)
A forest plot chart titled 'Results for Subgroups in MERIT-HF' displaying the relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure, comparing metoprolol succinate extended-release tablets versus placebo. The chart includes subgroups based on geographic region, NYHA class, ejection fraction, etiology, sex, race, prior myocardial infarction, diabetes mellitus, hypertension, and heart rate.*
FDA Label Image

Metoprolol Succinate Extended-release Tab Usp 50mg (00df8655 C4ff 481f Bd4f E43b69b3a059 03)

Metoprolol Succinate Extended-release Tab Usp 50mg (00df8655 C4ff 481f Bd4f E43b69b3a059 03)
This label panel for Metoprolol Succinate Extended-Release Tablets USP 50 mg includes dosage form and strength information, manufacturer details (Cipla USA, Inc.), storage instructions, and bilingual dosage directions in English and Spanish. It also contains cautionary statements about drug transfer and placeholders for batch, lot, and expiration data, along with barcodes and identifiers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.